ARTICLE | Company News
Plexcera licenses recombinant ceramidase from Mount Sinai
September 13, 2013 11:21 PM UTC
The Icahn School of Medicine at Mount Sinai Hospital (New York, N.Y.) granted Plexcera Therapeutics LLC (Vero Beach, Fla.) exclusive, worldwide rights to develop and commercialize recombinant human ac...